Tumor Immunology and Immunotherapy

​Nov. 27-30, 2018
Loews Miami Beach Hotel
Miami Beach, Florida

EXTENDED Advance Registration Deadline: Friday, Oct. 19, 2018, 11:59 p.m. ET

Conference Cochairs
James P. Allison,
The University of Texas MD Anderson Cancer Center, Houston, Texas
Lisa M. Coussens, Oregon Health and Science University Knight Cancer Institute, Portland, Oregon
Ira Mellman, Genentech, Inc., San Francisco, California
Drew M. Pardoll, Johns Hopkins Sydney Kimmel Comprehensive Cancer Center, Baltimore, Maryland

​This AACR Special Conference on Tumor Immunology and Immunotherapy is designed to integrate multidisciplinary facets of basic cancer immunology and immunotherapy to broaden our understanding of ways to harness the immune system to treat cancer. The hallmark of this series is also to encourage the effective exchange of ideas between basic cancer immunologists, non-immunologists, and clinical oncologists in order to develop approaches that translate to outcomes. This year’s program will feature international leaders in the field, who will expand our knowledge of the microbiome; metabolic regulation; oncogenic, myeloid, and vascular pathways; and targeted therapies. These world-renowned oncologists and scientists will offer new insights on systems biology, checkpoints, combination therapies, and molecular targets, all in the pursuit of finding new ways to manipulate the tumor immune microenvironment and creating better treatments. Please join in the conversation and network with investigators, from basic to translational scientists, from academia to industry.

Lead Supporter

Bristol-Myers Squibb

Professional Educational Grants






Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available